Chronic Urticaria

Chronic urticaria

50. Kolkhir, P., Muñoz, M., Terhorst-Molawi, D., Church, M. K., and Maurer, M.+: Chronic urticaria. In: Kenakin, T. editor: Comprehensive Pharmacology. Elsevier, 2022

bc.50

Expert consensus on the use of omalizumab in chronic urticaria in China

173.

Zhao, Z.+, Cai, T., Chen, H., Chen, L., Chen, Y., Gao, X., Gao, X., Geng, S., Guo, Y., Hao, F., Hao, G., Hu, Y., Jin, H., Jin, Z., Li, C., Li, H., Li, J., Li, Y., Liang, Y., Liu, G., Liu, Q., Long, H., Ma, L., Shang, Y., Song, Y., Song, Z., Su, X., Sui, H., Sun, Q., Sun, Y., Tang, J., Tong, X., Wang, H., Wang, G., Wang, L., Wang, S., Xiang, L., Xiao, T., Xie, Z., Ye, L., Yu, Y., Zhang, C., Zhang, L., Zhang, S., Zheng, R., Zhi, L., Zhou, W., Zou, Y., and Maurer, M.+: Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ. J. 2021: 14; e100610. IF: 5.52

r.173

How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

433. Cherrez-Ojeda, I.+, Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., Magalhaes, E., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., and Maurer, M.: How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ. J. 2021: 14; e100542. IF: 5.52

o.433

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

415. Kocatürk, E.+, Salman, A., Cherrez-Ojeda, I., Criado, P. R., Peter, J., Comert-Ozer, E., Abuzakouk, M., Agondi, C. R., Al-Ahmad, M., Altrichter, S., Arnaout, R., Arruda, K. L., Asero, R., Bauer, A., Ben-Shoshan, M., Bernstein, J. A., Bizjak, M., Boccon-Gibod, I., Bonnekoh, H., Bouillet, L., Brzoza, Z., Busse, P., Campos, R. A., Carne, E., Conlon, N., Criado, R. F., de Souza Lima, E. M., Demir, S., Dissemond, J., Doğan Günaydın, S., Dorofeeva, I., Ensina, L. F., Ertaş, R., Ferrucci, M. S., Figueras-Nart, I., Fomina, D., Franken, S. M., Fukunaga, A., Giménez-Arnau, A. M., Godse, K., Gonçalo, M., Gotua, M., Grattan, C., Guillet, C., Inomata, N., Jakob, T., Karakaya, G., Kasperska-Zając, A., Katelaris, C. H., Košnik, M., Krasowska, D., Kulthanan, K., Kumaran, S. M., Lang, C., Larco-Sousa, J. I., Lazaridou, E., Leslie,  T. A., Lippert, U., Llosa, O. C., Makris, M., Marsland, A., Medina, I. V., Meshkova, R., Palitot, E. B., Parisi, C. A. S., Pickert, J., Ramon, G.D., Rodríguez-Gonzalez, M., Rosario, N., Rudenko, M., Rutkowski, K., Sánchez, J., Schliemann, S., Sekerel, B. E., Serpa, F. S., Serra-Baldrich, E., Song, Z., Soria, A., Staevska, M., Staubach, P., Tagka, A., Takahagi, S., Thomsen, S. F., Treudler, R., Vadasz, Z., Valle, S. O. R., Van Doorn, M. B. A., Vestergaard, C., Wagner, N., Wang, D., Wang, L., Wedi, B., Xepapadaki, P., Yücel, E., Zalewska-Janowska, A., Zhao, Z., Zuberbier, T., and Maurer, M.+: The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy 2021: 76; 816-830. IF: 14.71

o.415

Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria

414. Kolkhir, P., Altrichter, S., Asero, R., Daschner, A., Ferrer, M., Giménez-Arnau, A., Hawro, T., Jakob, T., Kinaciyan, T., Kromminga, A., Konstantinou, G. N. Makris, M., Metz, M., Stahl Skov, P., Staubach, P., Sussman, G., Zhang, K., and Maurer, M.+: Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 545-559. IF: 5.10

o.414

© 2024 Marcus Maurer